Authors are required to submit a graphic entry for the Table of Contents (TOC) in conjunction with the manuscript title. This graphic should capture the readers' attention and give readers a visual impression of the essence of the paper. Labels, formulae, or numbers within the graphic must be legible at publication size. Tables or spectra are not acceptable. Color graphics are highly encouraged. The resolution of the figure should be at least 600 dpi. The size should be at least 50 mm 脳 80 mm with a rectangular shape (ideally, the ratio of height to width should be less than 1 and larger than 5/8). One to two sentences should be written below the figure to summarize the paper. To create the TOC, please insert your image in the template box below. Fonts, size, and spaces should not be changed.Highly biocompatible carbon nanodots were synthesized, which are abundant in hydroxyl functional groups on particle surface. Interestingly, the nanoparticles display divergent antiproliferative activities against two ovarian choriocarcinoma cell lines, which may be further explored for cancer drug discovery.
ABSTRACTThe toxicity of nanoparticles in a biological system is an integration of effects arising from surface functionality, particle size and ionic dissolution etc. Its complexity suggests that generalization on a material's toxicity may be inappropriate. Moreover, from medicinal point of view, toxicity can be used for treatment of malignant cells, such as cancer. In this study, highly biocompatible carbon nanodots (named gCDs) were synthesized by reacting citric acid and urea in glycerol, which resulted in abundant hydroxyl functional groups on particle surface. gCDs show excitation-dependent photoluminescence, but with brighter green to yellow emission. Importantly, a series of toxicity assessments showed that as-synthesized gCDs possess exceptional biocompatibilities to various biological entities including 18 bacteria species, Petunia axillaris seedlings and Artemia franciscana nauplii. Furthermore, the particles were shown to have low-to non-toxic effects on human embryonic kidney (HEK-293) cell lines, breast (MCF-7), oral squamous (CAL-27) carcinoma cell lines. Of particular interest, the gCDs display antiproliferative activities against ovarian choriocarcinoma cells (JAr / Jeg-3 cell lines), which may be further explored for cancer drug discovery.